Multiple Choice
The percutaneous introduction of idarucizumab dabigatran reversal agent into a peripheral vein, new technology group 1 is reported with code _____.
A) XW01331
B) XW04331
C) XW03321
D) XW03331
Correct Answer:

Verified
Correct Answer:
Verified
Related Questions
Q12: The fourth-character value for the New Technology
Q13: In the New Technology section of ICD-10-PCS,
Q14: In Code XV508A4, the sixth character, A,
Q15: Percutaneous introduction of bezlotoxumab monoclonal antibody into
Q16: In Table XR2, the R denotes _.<br>A)
Q18: In Table XW0, the character 5 value
Q19: In Table XRG, the only approach is
Q20: Which of the following is used to
Q21: In the New Technology section of ICD-10-PCS,
Q22: In Table XW0, a fourth-character value of